Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05010083 · ClinicalTrials.gov registry record · Phase 1
The University of Michigan OWL (Online Wellness and Lifestyle) Study
A Phase 1 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT05010083: Completed Phase 1 study, sponsored by University of Michigan.
NCT05010083 is a Phase 1 study that has completed, run by University of Michigan. The registered enrollment target is 17 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05010083, a Phase 1 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this trial is to pilot test our existing very low carbohydrate diet intervention, adapted for young adults.
Primary Outcome
Measured with bodyweight scale
Interventions
- BEHAVIORAL diet and lifestyle program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-08-23 |
| Est. Completion | 2022-06-01 |
| Phase | Phase 1 |
What the finished NCT05010083 record still lists
NCT05010083 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (72% lower).
The record links to 0 conditions, and to 1 intervention - of which diet and lifestyle program is the first listed.
NCT05010083 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05010083 about?
NCT05010083 is a clinical study titled "The University of Michigan OWL (Online Wellness and Lifestyle) Study". The goal of this trial is to pilot test our existing very low carbohydrate diet intervention, adapted for young adults.
What is the current status of trial NCT05010083?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2021-08-23. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT05010083?
The interventions under investigation include: diet and lifestyle program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05010083?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05010083's enrollment target sits among peer trials
17 1785th of 2000 higher than 215 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI